Neurogene (NGNE) Enterprise Value Growth (1y) (2014 - 2026)
Neurogene (NGNE) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.89% |
| Dec 31, 2025 | 13.89% |
| Sep 30, 2025 | -90.95% |
| Jun 30, 2025 | -78.37% |
| Mar 31, 2025 | -72.59% |
| Dec 31, 2024 | -58.45% |
| Sep 30, 2024 | -77.05% |
| Jun 30, 2024 | -87.55% |
| Mar 31, 2024 | -103.19% |
| Dec 31, 2023 | -140.37% |
| Sep 30, 2023 | 26.55% |
| Jun 30, 2023 | 29.53% |
| Mar 31, 2023 | 34.84% |
| Dec 31, 2022 | 42.43% |
| Sep 30, 2022 | 31.01% |
| Jun 30, 2022 | 29.09% |
| Mar 31, 2022 | 28.22% |
| Dec 31, 2021 | 26.01% |
| Sep 30, 2021 | 22.98% |
| Jun 30, 2021 | -26.73% |